/
China Pharma Holdings Inc. (the Company , China Pharma , we , us , or our ) is a Nevada holding company. China Pharma is not a Chinese operating company and all the operations are conducted by our wholly owned subsidiary, Hainan Helpson Medical and Biotechnology Co., Ltd. ( Helpson ) and Helpson s subsidiaries in China.
The business is unprofitable at the operating level (-78.16% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 8.5% YoY. The question is whether this is cyclical or a structural shift.
Net debt of $1M represents 14.3x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
$4M
▼ -8.5% YoY
Net Income (TTM)
-$4M
▲ +32.7% YoY
Op. Margin
-90.13%
▲ +23.2pp YoY
ROIC
-14.07%
▲ +25.7pp YoY
Cash Flow & Balance Sheet
FCF (FY)
$89K
▲ +120.0% YoY
Op. Cash Flow (TTM)
$167K
▲ +136.5% YoY
Net Debt
$1M
Cash & Equiv.
$168K
5Y CAGR: -17.5%
Continue Research